A laboratory test — or assay — developed in Sudbury, Ont., to measure the effectiveness of chemotherapy is one step closer to becoming commercially available. The Veridapt DX test, developed by Rna ...

Early pregnancy depends on a remarkable act of coordination. Before the placenta can nourish a growing fetus, the embryo must securely "land" and connect with the mother's blood supply—a process ...

Nordic Semiconductor, a global leader in low-power wireless connectivity solutions, today announces a major step forward in its edge AI strategy, expanding its next-generation, ultra-low-power ...

Early pregnancy depends on a remarkable act of coordination. Before the placenta can nourish a growing fetus, the embryo must ...

In December 2025, Tenaya closed an underwritten public offering of 50,000,000 total units at a public offering price of $1.20 per unit, consisting of one share of Tenaya common stock and one warrant ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...

Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...

The draft notification has been released for public consultation, inviting stakeholders to submit comments and suggestions within the prescribed period.

Q4 2025 Management View CEO Alison Moore stated that Codexis is now focused on RNA medicine and has developed the ECO Synthesis manufacturing platform to address challenges in current siRNA production ...